Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 185

1.

Amide proton transfer imaging for differentiating benign ovarian cystic lesions: Potential of first time right.

Ishimatsu K, Nishie A, Takayama Y, Asayama Y, Ushijima Y, Kakihara D, Morita K, Takao S, Sonoda K, Ohishi Y, Honda H.

Eur J Radiol. 2019 Sep 7;120:108656. doi: 10.1016/j.ejrad.2019.108656. [Epub ahead of print]

PMID:
31541877
2.

Uptake of 18F-FDG in Adrenal Adenomas Is Associated With Unenhanced CT Value and Constituent Cells.

Murayama R, Nishie A, Hida T, Baba S, Inokuchi J, Oda Y, Honda H.

Clin Nucl Med. 2019 Sep 4. doi: 10.1097/RLU.0000000000002759. [Epub ahead of print]

PMID:
31490313
3.

Intravoxel incoherent motion magnetic resonance imaging for assessment of chronic pancreatitis with special focus on its early stage.

Fujita N, Nishie A, Asayama Y, Ishigami K, Fujimori N, Ito T, Honda H.

Acta Radiol. 2019 Sep 2:284185119872687. doi: 10.1177/0284185119872687. [Epub ahead of print] No abstract available.

PMID:
31475847
4.

Superparamagnetic iron-oxide-enhanced diffusion-weighted magnetic resonance imaging for the diagnosis of intrapancreatic accessory spleen.

Ishigami K, Nishie A, Nakayama T, Asayama Y, Kakihara D, Fujita N, Ushijima Y, Okamoto D, Ohtsuka T, Mori Y, Ito T, Mochidome N, Honda H.

Abdom Radiol (NY). 2019 Oct;44(10):3325-3335. doi: 10.1007/s00261-019-02189-8.

PMID:
31420705
5.

Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.

Kromrey ML, Hori M, Goshima S, Kozaka K, Hyodo T, Nakamura Y, Nishie A, Tamada T, Shimizu T, Kanki A, Motosugi U.

Eur Radiol. 2019 Jul 23. doi: 10.1007/s00330-019-06358-7. [Epub ahead of print]

PMID:
31338655
6.

Imaging features of undifferentiated carcinoma of the pancreas.

Ishigami K, Nishie A, Yamamoto T, Asayama Y, Ushijima Y, Kakihara D, Fujita N, Morita K, Ohtsuka T, Kawabe K, Mochidome N, Honda H.

J Med Imaging Radiat Oncol. 2019 Oct;63(5):580-588. doi: 10.1111/1754-9485.12925. Epub 2019 Jul 3.

PMID:
31268241
7.

Papillary renal cell carcinoma with massive hematoma mimicking hemangioma.

Hiraki Y, Okamoto D, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Fujita N, Eto M, Kinoshita F, Honda H.

Radiol Case Rep. 2019 Jun 6;14(8):1003-1006. doi: 10.1016/j.radcr.2019.05.025. eCollection 2019 Aug.

8.

CT gastrography "wall-carving technique" of gastric cancer: impact of contrast enhancement based on layer depth.

Tsurumaru D, Nishimuta Y, Muraki T, Asayama Y, Nishie A, Oki E, Honda H.

Jpn J Radiol. 2019 Aug;37(8):597-604. doi: 10.1007/s11604-019-00845-z. Epub 2019 Jun 8.

PMID:
31177473
9.

Usefulness of a Pretreatment CT-Based Modified RENAL Nephrometry Score in Predicting Renal Function After Cryotherapy for T1a Renal Mass.

Asayama Y, Nishie A, Ushijima Y, Okamoto D, Morita K, Takao S, Kakihara D, Ishimatsu K, Ishigami K, Fujita N, Honda H.

Cardiovasc Intervent Radiol. 2019 Aug;42(8):1128-1134. doi: 10.1007/s00270-019-02238-1. Epub 2019 May 9.

PMID:
31073824
10.

Image quality and radiation dose of renal perfusion CT with low-dose contrast agent: a comparison with conventional CT using a 320-row system.

Asayama Y, Nishie A, Ishigami K, Ushijima Y, Kakihara D, Fujita N, Morita K, Ishimatsu K, Takao S, Honda H.

Clin Radiol. 2019 Aug;74(8):650.e13-650.e18. doi: 10.1016/j.crad.2019.03.017. Epub 2019 Apr 20.

PMID:
31014571
11.

Prediction of Liver Fibrosis Using CT Under Respiratory Control: New Attempt Using Deformation Vectors Obtained by Non-rigid Registration Technique.

Nishie A, Akahori S, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Nakayama T, Takayama Y, Fujita N, Morita K, Ishimatsu K, Takao S, Yoshizumi T, Kohashi K, Li Y, Honda H.

Anticancer Res. 2019 Mar;39(3):1417-1424. doi: 10.21873/anticanres.13257.

PMID:
30842177
12.

Impact of body mass index on CT attenuation of adrenal adenoma.

Nishie A, Asayama Y, Ishigami K, Ushijima Y, Kakihara D, Nakayama T, Fujita N, Morita K, Ishimatsu K, Takao S, Hida T, Sugimoto M, Honda H.

Eur J Radiol. 2018 Nov;108:184-188. doi: 10.1016/j.ejrad.2018.09.033. Epub 2018 Oct 2.

PMID:
30396653
13.

Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT.

Tsurumaru D, Nishimuta Y, Muraki T, Asayama Y, Nishie A, Oki E, Honda H.

Eur J Radiol. 2018 Nov;108:165-171. doi: 10.1016/j.ejrad.2018.09.030. Epub 2018 Sep 29.

PMID:
30396650
14.

Slow Gait Speed Is a Risk Factor for Complications After Hepatic Resection.

Itoh S, Yoshizumi T, Sakata K, Motomura T, Mano Y, Toshima T, Harimoto N, Harada N, Ikegami T, Soejima Y, Kusaba R, Kamishima T, Nishie A, Maehara Y.

J Gastrointest Surg. 2019 Sep;23(9):1810-1816. doi: 10.1007/s11605-018-3993-5. Epub 2018 Oct 8.

PMID:
30298420
15.

In Vitro and In Vivo Detection of Drug-induced Apoptosis Using Annexin V-conjugated Ultrasmall Superparamagnetic Iron Oxide (USPIO): A Pilot Study.

Nishie A, Togao O, Tamura C, Yamato M, Ichikawa K, Nohara S, Ito Y, Kato N, Yoshise S, Honda H.

Magn Reson Med Sci. 2019 Apr 10;18(2):142-149. doi: 10.2463/mrms.mp.2017-0157. Epub 2018 Oct 2.

16.

Relationship Among Tumor Attenuation Value of Pre-contrast Computed Tomography (CT), Washout Rate and Constituent Cells in Adrenal Adenoma: Proposition of a New Approach for Diagnosing Adrenal Adenoma on Dynamic CT.

Nishie A, Sugimoto M, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Yokomizo A, Tatsugami K, Honda H.

Anticancer Res. 2018 Aug;38(8):4767-4773. doi: 10.21873/anticanres.12785.

PMID:
30061247
17.

A case of pseudoglandular hepatocellular carcinoma: The usefulness of a multimodal approach.

Watanabe H, Asayama Y, Nishie A, Ishigami K, Ushijima Y, Okamoto D, Fujita N, Yoshizumi T, Oda Y, Honda H.

Radiol Case Rep. 2018 Apr 18;13(3):689-692. doi: 10.1016/j.radcr.2018.03.022. eCollection 2018 Jun.

18.

Amide proton transfer imaging to predict tumor response to neoadjuvant chemotherapy in locally advanced rectal cancer.

Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Tsurumaru D, Togao O, Sagiyama K, Manabe T, Oki E, Kubo Y, Hida T, Hirahashi-Fujiwara M, Keupp J, Honda H.

J Gastroenterol Hepatol. 2019 Jan;34(1):140-146. doi: 10.1111/jgh.14315. Epub 2018 Jul 2.

PMID:
29900583
19.

Amide proton transfer imaging can predict tumor grade in rectal cancer.

Nishie A, Takayama Y, Asayama Y, Ishigami K, Ushijima Y, Okamoto D, Fujita N, Tsurumaru D, Togao O, Manabe T, Oki E, Kubo Y, Hida T, Hirahashi-Fujiwara M, Keupp J, Honda H.

Magn Reson Imaging. 2018 Sep;51:96-103. doi: 10.1016/j.mri.2018.04.017. Epub 2018 May 2.

PMID:
29729438
20.

Tumor Enhancement on Dynamic CT: A Predictive Factor for Recurrence After Nephrectomy in Localized T1 Clear Cell Renal Cell Carcinoma.

Maehara J, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Sugimoto M, Inokuchi J, Honda H.

Anticancer Res. 2018 Apr;38(4):2377-2383.

PMID:
29599364
21.

Dynamic flow imaging using 320-detector row CT and motion coherence analysis in coronary aneurysms associated with Kawasaki disease.

Shimomiya Y, Nagao M, Yamasaki Y, Shirasaka T, Kondo M, Kojima T, Nishie A, Yamamura K, Honda H.

Cardiol Young. 2018 Mar;28(3):416-420. doi: 10.1017/S1047951117002293. Epub 2017 Dec 14.

PMID:
29239297
22.

Differential Diagnosis of Pancreatic Epidermoid Cyst Without a Solid Component (Residual Splenic Tissue) vs. Mucinous Cystic Neoplasm.

Ishigami K, Nishie A, Irie H, Asayama Y, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Ohtsuka T, Ito T, Mochidome N, Honda H.

J Gastrointest Cancer. 2019 Mar;50(1):91-97. doi: 10.1007/s12029-017-0035-6.

PMID:
29218653
23.

Histopathologic diversity of gastric cancers: Relationship between enhancement pattern on dynamic contrast-enhanced CT and histological type.

Tsurumaru D, Miyasaka M, Muraki T, Nishie A, Asayama Y, Oki E, Oda Y, Honda H.

Eur J Radiol. 2017 Dec;97:90-95. doi: 10.1016/j.ejrad.2017.10.018. Epub 2017 Oct 26.

PMID:
29153374
24.

Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed.

Harimoto N, Yoshizumi T, Izumi T, Motomura T, Harada N, Itoh S, Ikegami T, Uchiyama H, Soejima Y, Nishie A, Kamishima T, Kusaba R, Shirabe K, Maehara Y.

Transplant Proc. 2017 Nov;49(9):2144-2152. doi: 10.1016/j.transproceed.2017.09.017.

PMID:
29149975
25.

Amide Proton Transfer MR Imaging of Endometrioid Endometrial Adenocarcinoma: Association with Histologic Grade.

Takayama Y, Nishie A, Togao O, Asayama Y, Ishigami K, Ushijima Y, Okamoto D, Fujita N, Sonoda K, Hida T, Ohishi Y, Keupp J, Honda H.

Radiology. 2018 Mar;286(3):909-917. doi: 10.1148/radiol.2017170349. Epub 2017 Oct 30.

PMID:
29083987
26.

Differentiation of hypointense nodules on gadoxetic acid-enhanced hepatobiliary-phase MRI using T2 enhanced spin-echo imaging with the time-reversed gradient echo sequence: An initial experience.

Yoneyama M, Takayama Y, Nishie A, Nakamura M, Katsumata Y, Takemura A, Obara M, Okuaki T, Honda H, Van Cauteren M.

Eur J Radiol. 2017 Oct;95:325-331. doi: 10.1016/j.ejrad.2017.08.025. Epub 2017 Aug 30.

PMID:
28987688
27.

Should the Selective Arterial Secretagogue Injection Test for Insulinoma Localization Be Evaluated at 60 or 120 Seconds?

Ueda K, Ito T, Kawabe K, Lee L, Fujiyama T, Tachibana Y, Miki M, Yasunaga K, Takaoka T, Nishie A, Asayama Y, T Jensen R, Ogawa Y.

Intern Med. 2017 Nov 15;56(22):2985-2991. doi: 10.2169/internalmedicine.9107-17. Epub 2017 Sep 25.

28.

The prevalence of transpancreatic common hepatic artery and coexisting variant anatomy.

Ishigami K, Nishie A, Asayama Y, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Yoshizumi T, Harimoto N, Ohtsuka T, Nakata K, Honda H.

Clin Anat. 2018 May;31(4):598-604. doi: 10.1002/ca.22957. Epub 2017 Dec 8.

PMID:
28726321
29.

Image quality and diagnostic performance of free-breathing diffusion-weighted imaging for hepatocellular carcinoma.

Takayama Y, Nishie A, Asayama Y, Ishigami K, Kakihara D, Ushijima Y, Fujita N, Shirabe K, Takemura A, Honda H.

World J Hepatol. 2017 May 18;9(14):657-666. doi: 10.4254/wjh.v9.i14.657.

30.

Does apparent diffusion coefficient predict the degree of liver regeneration of donor and recipient after living donor liver transplantation?

Morita K, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Ikegami T, Yoshizumi T, Shirabe K, Honda H.

Eur J Radiol. 2017 May;90:146-151. doi: 10.1016/j.ejrad.2017.02.041. Epub 2017 Mar 1.

PMID:
28583626
31.

Mucinous nonneoplastic cyst of the pancreas: CT and MRI appearances.

Ishigami K, Nishie A, Mochidome N, Asayama Y, Ushijima Y, Kakihara D, Okamoto D, Fujita N, Ohtsuka T, Miyasaka Y, Hida T, Yoshizumi T, Honda H.

Abdom Radiol (NY). 2017 Dec;42(12):2827-2834. doi: 10.1007/s00261-017-1204-6.

PMID:
28567485
32.

Predictors of therapeutic effect of transarterial chemoembolisation using drug-eluting beads for hepatocellular carcinoma.

Asayama Y, Okamoto D, Ushijima Y, Nishie A, Ishigami K, Takayama Y, Fujita N, Honda H.

Clin Radiol. 2017 Sep;72(9):780-785. doi: 10.1016/j.crad.2017.03.023. Epub 2017 Apr 22.

PMID:
28442142
33.

T mapping improvement using stretched-type adiabatic locking pulses for assessment of human liver function at 3T.

Okuaki T, Takayama Y, Nishie A, Ogino T, Obara M, Honda H, Miyati T, Van Cauteren M.

Magn Reson Imaging. 2017 Jul;40:17-23. doi: 10.1016/j.mri.2017.03.006. Epub 2017 Mar 28.

PMID:
28363761
34.

Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan.

Nishie A, Goshima S, Haradome H, Hatano E, Imai Y, Kudo M, Matsuda M, Motosugi U, Saitoh S, Yoshimitsu K, Crawford B, Kruger E, Ball G, Honda H.

Clin Ther. 2017 Apr;39(4):738-750.e4. doi: 10.1016/j.clinthera.2017.03.006. Epub 2017 Mar 29.

PMID:
28363694
35.

Diffuse-type gastric cancer: specific enhancement pattern on multiphasic contrast-enhanced computed tomography.

Tsurumaru D, Miyasaka M, Muraki T, Asayama Y, Nishie A, Oki E, Hirahashi M, Hida T, Honda H.

Jpn J Radiol. 2017 Jun;35(6):289-295. doi: 10.1007/s11604-017-0631-1. Epub 2017 Mar 9.

PMID:
28281045
36.

A Retroperitoneal Isolated Enteric Duplication Cyst Mimicking a Teratoma: A Case Report and Literature Review.

Momosaka D, Ushijima Y, Nishie A, Asayama Y, Ishigami K, Takayama Y, Okamoto D, Fujita N, Ikeda T, Uchida K, Sugimoto M, Kohashi K, Honda H.

Case Rep Radiol. 2016;2016:6976137. doi: 10.1155/2016/6976137. Epub 2016 Dec 19.

37.

Mass-forming Retroperitoneal Endometriosis Including a Fat Component: A Diagnostic Dilemma.

Kyuragi Y, Nishie A, Takayama Y, Asayama Y, Ishigami K, Ueki T, Hirahashi M, Honda H.

Magn Reson Med Sci. 2017 Jul 10;16(3):181-182. doi: 10.2463/mrms.ci.2016-0078. Epub 2016 Dec 22. No abstract available.

38.

Impact of hybrid iterative reconstruction on unenhanced liver CT.

Kondo M, Nishie A, Fujita N, Morita K, Shirasaka T, Arimura H, Nakamura Y, Honda H.

Br J Radiol. 2017 Feb;90(1070):20150670. doi: 10.1259/bjr.20150670. Epub 2016 Dec 20.

39.

Clinical Significances of Preoperative Classification of Intrahepatic Cholangiocarcinoma: Different Characteristics of Perihilar vs. Peripheral ICC.

Yamashita YI, Wang H, Kurihara T, Tsujita E, Nishie A, Imai K, Hashimoto D, Chikamoto A, Aishima S, Baba H.

Anticancer Res. 2016 Dec;36(12):6563-6569.

PMID:
27919984
40.

Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry.

Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Shirabe K, Yoshizumi T, Kotoh K, Furusyo N, Hida T, Oda Y, Fujioka T, Honda H.

World J Gastroenterol. 2016 Oct 28;22(40):8949-8955.

41.

Prognostic significance of contrast-enhanced CT attenuation value in extrahepatic cholangiocarcinoma.

Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Ohtsuka T, Yoshizumi T, Aishima S, Oda Y, Honda H.

Eur Radiol. 2017 Jun;27(6):2563-2569. doi: 10.1007/s00330-016-4621-y. Epub 2016 Oct 17.

PMID:
27752833
42.

Functional remnant liver assessment predicts liver-related morbidity after hepatic resection in patients with hepatocellular carcinoma.

Itoh S, Yoshizumi T, Shirabe K, Kimura K, Okabe H, Harimoto N, Ikegami T, Uchiyama H, Nishie A, Maehara Y.

Hepatol Res. 2017 Apr;47(5):398-404. doi: 10.1111/hepr.12761. Epub 2016 Sep 12.

PMID:
27283504
43.

Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma.

Itoh S, Yoshizumi T, Kimura K, Okabe H, Harimoto N, Ikegami T, Uchiyama H, Shirabe K, Nishie A, Maehara Y.

Anticancer Res. 2016 Jun;36(6):3029-34.

PMID:
27272822
44.

Fatty change in moderately and poorly differentiated hepatocellular carcinoma on MRI: a possible mechanism related to decreased arterial flow.

Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Kubo Y, Aishima S, Yoshizumi T, Honda H.

Clin Radiol. 2016 Dec;71(12):1277-1283. doi: 10.1016/j.crad.2016.04.020. Epub 2016 Jul 7.

PMID:
27210243
45.

Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.

Fujita N, Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Moirta K, Shirabe K, Aishima S, Wang H, Oda Y, Honda H.

Eur Radiol. 2017 Feb;27(2):498-506. doi: 10.1007/s00330-016-4386-3. Epub 2016 May 10.

PMID:
27165138
46.

Balanced MR cholangiopancreatography with motion-sensitised driven-equilibrium (MSDE) preparation: feasibility of Gd-EOB-DTPA-enhanced biliary examination.

Nakayama T, Yoshiura T, Nishie A, Asayama Y, Ishigami K, Kakihara D, Takayama Y, Hatakenaka M, Obara M, Honda H.

Clin Radiol. 2016 Dec;71(12):1284-1288. doi: 10.1016/j.crad.2016.03.019. Epub 2016 May 1.

PMID:
27146898
47.

Histogram analysis of noncancerous liver parenchyma on gadoxetic acid-enhanced MRI: predictive value for liver function and pathology.

Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Yoshizumi T, Hida T, Honda H.

Abdom Radiol (NY). 2016 Sep;41(9):1751-7. doi: 10.1007/s00261-016-0753-4.

PMID:
27138437
48.

Quantification of coronary flow using dynamic angiography with 320-detector row CT and motion coherence image processing: Detection of ischemia for intermediate coronary stenosis.

Nagao M, Yamasaki Y, Kamitani T, Kawanami S, Sagiyama K, Yamanouchi T, Shimomiya Y, Matoba T, Mukai Y, Odashiro K, Baba S, Maruoka Y, Kitamura Y, Nishie A, Honda H.

Eur J Radiol. 2016 May;85(5):996-1003. doi: 10.1016/j.ejrad.2016.02.027. Epub 2016 Mar 2.

PMID:
27130062
49.

Prognostic Significance of a Minute Amount of Ascites During Chemoradiotherapy for Locally Advanced Pancreatic Cancer.

Shinoto M, Nakamura K, Shioyama Y, Sasaki T, Nishie A, Asayama Y, Ohga S, Yoshitake T, Terashima K, Asai K, Matsumoto K, Honda H.

Anticancer Res. 2016 Apr;36(4):1879-84.

PMID:
27069174
50.

Hemodynamic changes under balloon occlusion of hepatic artery: predictor of the short-term therapeutic effect of balloon-occluded transcatheter arterial chemolipiodolization using miriplatin for hepatocellular carcinoma.

Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Morita K, Honda H.

Springerplus. 2016 Feb 24;5:157. doi: 10.1186/s40064-016-1880-7. eCollection 2016.

Supplemental Content

Loading ...
Support Center